Clinical Characteristics and Predictors of Complications and Mortality in Hospitalized Octogenarian Patients with COVID-19: An Ambispective Study

Author:

Arroyo-Huidobro Marta1ORCID,Fontanet Natàlia Pallarès2,Cordomí Cristian Tebé3,Simonetti Antonella F.4,Pérez-López Carlos5,Abelenda-Alonso Gabriela6,Rombauts Alexander6,Bermudez Isabel Oriol7,Izquierdo Elisenda8,Díaz-Brito Vicente9,Molist Gemma10,Melis Guadalupe Gómez11,Videla Sebastian12,Soto Alfons López13,Carratalà Jordi14,Molinero Alejandro Rodriguez15

Affiliation:

1. Hospital Clínic de Barcelona: Hospital Clinic de Barcelona

2. Germans Trias i Pujol Research Institute and Hospital

3. Biostatistics Support and Research Unit, Germans Trias i Pujol Research Instituye and Hospital (IGTP)

4. Hospital de la Santa Creu i Sant Pau

5. Consorci Sanitari del Garraf: Consorci Sanitari Alt Penedes-Garraf

6. Bellvitge University Hospital: Hospital Universitari de Bellvitge

7. Department of Internal Medicine, Consorci Sanitari Integral

8. Hospital de Viladecans

9. Parc Sanitari Sant Joan de Déu: Parc Sanitari Sant Joan de Deu

10. IDIBELL: Institut d'Investigacio Biomedica de Bellvitge

11. Department of Statistics and Operations Research

12. Department of Clinical Pharmacology, Bellvitge University Hospital

13. Geriatric Unit, Deparment of Internal Medicine

14. Department of Infectious Diseases, Bellvitge University Hospital

15. Area de recerca, Consorci Sanitari Alt'Pènedes i Garraf

Abstract

Abstract Objective This study aimed to describe the clinical presentation of COVID-19 in hospitalized patients aged 80 or above and to identify predictors for death and complications throughout the epidemic waves of the disease. Methods This was an observational, multicenter, ambispective study conducted between March 2020 and August 2021 using data collected in five centers from southern metropolitan area of Barcelona (COVID-MetroSud cohort). Patients were grouped based on the pandemic waves of inclusion in the registry. Results A total of 1192 patients (mean [SD] age 85.7 [4.22] years) were included. The most frequently reported symptoms in all waves were fever (63.1%), cough (56.5%), dyspnea (48.2%), and asthenia (27.5%). Laboratory and radiological findings consistently showed abnormal bilateral chest X-ray results (72.5% of patients) and elevated inflammatory markers such as lactate dehydrogenase (mean [SD] 335 [188] U/L), C-reactive protein (CRP) (mean [SD] 110 [88.4] U/L), and ferritin (mean [SD] 842 [1561] U/L). Acute respiratory distress syndrome (43.7%), renal failure (19.2%), and alterations in baseline mental status (17.5%) were the most frequent complications. The overall mortality rate was 41.4% and declined across the epidemic waves. Age, diabetes mellitus, heart failure, dyspnea, and higher baseline levels of creatinine were identified as risk factors for general complications, while a higher Barthel index and presence of cough were found to be protective. Age, dyspnea, abnormal bilateral chest x-ray, CRP, and sodium were identified as risk factors for death. Conclusions This the first study that analyzed the clinical presentation of COVID-19 and the risk factors for complications and death in octogenarian hospitalized patients across the different waves of the disease.

Publisher

Research Square Platform LLC

Reference38 articles.

1. World Healt Organization. Coronavirus (COVID-19) Dashboard. Accessed May 9 (2023) https://covid19.who.int/

2. Ministerio de Sanidad España Situación actual enfermedad por nuevo coronavirus, COVID-19. Accessed May 9, 2023. https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm

3. Equipo COVID-19 (2023) RENAVE. Informe No 176. Situación de COVID-19 En España.; Accessed May 9, 2023. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx

4. Polypharmacy in older adults: the role of the advanced practitioner in oncology;Cope DG;J Adv Pract Oncol,2013

5. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes;Nikolich-Zugich J;Geroscience,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3